Filana Therapeutics (FLNA) EBT Margin (2010 - 2013)
Filana Therapeutics (FLNA) posted quarterly EBT Margin of 93.68% for Q4 2013, up 16645.0% year-over-year from N/an in Q4 2012, and up 340.7% quarter-over-quarter from 38.92% in Q3 2013.
Filana Therapeutics (FLNA) EBT Margin (2010 - 2013) Analysis & Trends
Filana Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 93.68% for Q4 2013.
- In Q4 2013, EBT Margin rose 16645.0% year-over-year to 93.68%; the TTM figure through Dec 2013 stood at 76.71% (up 10836.0% YoY), while the FY2013 annual figure was 76.54%, up 10818.0% from the prior year.
- EBT Margin for Q4 2013 stood at 93.68%, up from 38.92% in the prior quarter.
- The five-year high for EBT Margin was 93.68% in Q4 2013, with the low at 1663.31% in Q4 2011.
- The 4-year median for EBT Margin is 38.92% (2013), against an average of 177.48%.
- The sharpest annual moves came in 2011 and 2012: EBT Margin plunged 96895 bps in 2011, then soared 159053 bps in 2012.
- Filana Therapeutics' EBT Margin stood at 694.36% in 2010, then sank by 140 bps to 1663.31% in 2011, then surged by 96 bps to 72.77% in 2012, then jumped by 229 bps to 93.68% in 2013.
- Business Quant data shows FLNA's EBT Margin at 93.68% in Q4 2013, 38.92% in Q3 2013, and 15.36% in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 93.68% |
| Sep 30, 2013 | -38.92% |
| Jun 30, 2013 | -15.36% |
| Mar 31, 2013 | -20.84% |
| Dec 31, 2012 | -72.77% |
| Sep 30, 2012 | -56.88% |
| Jun 30, 2012 | -4.77% |
| Mar 31, 2012 | 1.01% |
| Dec 31, 2011 | -1,663.31% |
| Sep 30, 2011 | -29.65% |
| Jun 30, 2011 | -43.60% |
| Mar 31, 2011 | -14.80% |
| Dec 31, 2010 | -694.36% |
| Sep 30, 2010 | -54.30% |
| Jun 30, 2010 | -47.25% |